{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:26:40Z","timestamp":1792099600662,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Diseases Now"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.idnow.2025.105126","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:10Z","timestamp":1753891270000},"page":"105126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["Antibiotic combination indications for the treatment of community-acquired acute pneumonia"],"prefix":"10.1016","volume":"55","author":[{"given":"Pierre","family":"Fillatre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Blot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-9792","authenticated-orcid":false,"given":"Damien","family":"Basille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Tandjaoui-Lambiotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-4819","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idnow.2025.105126_b0005","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chest.2018.11.006","article-title":"Effect of combined \u03b2-lactam\/macrolide therapy on mortality according to the microbial etiology and inflammatory status of patients with community-acquired pneumonia","volume":"155","author":"Ceccato","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.idnow.2025.105126_b0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rmed.2018.05.020","article-title":"Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia","volume":"140","author":"Arnold","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.idnow.2025.105126_b0015","doi-asserted-by":"crossref","first-page":"18406","DOI":"10.1038\/s41598-019-54922-4","article-title":"Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis","volume":"9","author":"Ito","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.idnow.2025.105126_b0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jinf.2018.01.003","article-title":"Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: a propensity score analysis","volume":"76","author":"De La Calle","year":"2018","journal-title":"J Infect"},{"key":"10.1016\/j.idnow.2025.105126_b0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/thoraxjnl-2012-202296","article-title":"Single versus combination antibiotic therapy in adults hospitalised with community acquired pneumonia","volume":"68","author":"Rodrigo","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.idnow.2025.105126_b0030","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.idnow.2025.105126_b0035","first-page":"4","article-title":"Management of community-acquired pneumonia in adults: 2016 guideline update from the Dutch Working Party on Antibiotic Policy (SWAB) and Dutch Association of Chest Physicians (NVALT)","volume":"76","author":"Wiersinga","year":"2018","journal-title":"Neth J Med"},{"key":"10.1016\/j.idnow.2025.105126_b0040","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections - full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2025.105126_b0045","doi-asserted-by":"crossref","unstructured":"Dinh A, Barbier F, Bedos J-P, Blot M, Cattoir V, Claessens Y-E, et al. Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French radiology society (SFR) and the French emergency society (SFMU). Infect Dis Now. 2025;55:105034. doi: 10.1016\/j.idnow.2025.105034.","DOI":"10.1016\/j.idnow.2025.105034"},{"key":"10.1016\/j.idnow.2025.105126_b0050","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cmi.2023.04.008","article-title":"The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy","volume":"29","author":"Wijnakker","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2025.105126_b0055","unstructured":"Schweizerische Gesellschaft f\u00fcr Infektiologie [Internet]. 2020. Pneumonie \/ Ambulant-erworbene Pneumonie CAP [updated January 10, 2025; cited June 1, 2025]. Available from: https:\/\/ssi.guidelines.ch\/guideline\/3007\/de."},{"key":"10.1016\/j.idnow.2025.105126_b0060","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Pneumologie de Langue Fran\u00e7aise [Internet]. 2011. Antibioth\u00e9rapie par voie g\u00e9n\u00e9rale dans les infections respiratoires basses de l\u2019adulte. SPILF \u2013 AFSSAPS \u2013 SPLF J [cited June 17, 2025]. Available from: https:\/\/splf.fr\/antibiotherapie-par-voie-generale-dans-les-infections-respiratoires-basses-de-ladulte\/."},{"issue":"1","key":"10.1016\/j.idnow.2025.105126_b0065","article-title":"Adverse events in people taking macrolide antibiotics versus placebo for any indication","volume":"1","author":"Hansen","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.idnow.2025.105126_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f1235","article-title":"Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies","volume":"346","author":"Schembri","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.idnow.2025.105126_b0075","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1001\/jama.2014.4304","article-title":"Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia","volume":"311","author":"Mortensen","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.idnow.2025.105126_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1473-3099(19)30039-8","article-title":"Macrolide resistance in Streptococcus spp","volume":"19","author":"Tsuzuki","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.idnow.2025.105126_b0085","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/429242","article-title":"Predicting antimicrobial resistance in invasive pneumococcal infections","volume":"40","author":"Vanderkooi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105126_b0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2110-5820-1-48","article-title":"Combination antibiotic therapy for community-acquired pneumonia","volume":"1","author":"Caballero","year":"2011","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.idnow.2025.105126_b0095","doi-asserted-by":"crossref","first-page":"e713","DOI":"10.1093\/infdis\/jiae639","article-title":"Addition of macrolide antibiotics for hospital treatment of community-acquired pneumonia","volume":"231","author":"Wei","year":"2025","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idnow.2025.105126_b0100","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1186\/cc13095","article-title":"Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance","volume":"17","author":"Adrie","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.idnow.2025.105126_b0105","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.idnow.2025.105126_b0110","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2025.105126_b0115","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.idnow.2025.105126_b0120","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","article-title":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial","volume":"397","author":"Dinh","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idnow.2025.105126_b0185","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2213-2600(23)00412-5","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.idnow.2025.105126_b0125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/resp.12835","article-title":"Beta-lactam plus macrolides or beta-lactam alone for community-acquired pneumonia: a systematic review and meta-analysis","volume":"21","author":"Horita","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.idnow.2025.105126_b0140","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1093\/jac\/dku033","article-title":"\u03b2-Lactam\/macrolide dual therapy versus \u03b2-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"69","author":"Nie","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2025.105126_b0145","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/jac\/dkx007","article-title":"Antimicrobial strategy for severe community-acquired legionnaires\u2019 disease: a multicentre retrospective observational study","volume":"72","author":"Cecchini","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idnow.2025.105126_b0150","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1093\/cid\/civ157","article-title":"The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with legionella pneumonia","volume":"60","author":"Gershengorn","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105126_b0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijantimicag.2006.03.029","article-title":"Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumonia","volume":"28","author":"Grau","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.idnow.2025.105126_b0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jinf.2009.06.008","article-title":"The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila","volume":"59","author":"Nakamura","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.idnow.2025.105126_b0165","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/428049","article-title":"Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides","volume":"40","author":"Bl\u00e1zquez Garrido","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idnow.2025.105126_b0170","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/1469-0691.12022","article-title":"Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia\u2013results of a prospective observational study","volume":"19","author":"Sicot","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.idnow.2025.105126_b0175","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idnow.2025.105126_b0180","doi-asserted-by":"crossref","DOI":"10.1128\/aac.02298-21","article-title":"The azithromycin pro-drug CSY5669 boosts bacterial killing while attenuating lung inflammation associated with pneumonia caused by methicillin-resistant Staphylococcus aureus","volume":"66","author":"Saris","year":"2022","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Infectious Diseases Now"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666991925001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T02:36:36Z","timestamp":1756953396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666991925001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2666991925001058"],"URL":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105126","relation":{},"ISSN":["2666-9919"],"issn-type":[{"value":"2666-9919","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic combination indications for the treatment of community-acquired acute pneumonia","name":"articletitle","label":"Article Title"},{"value":"Infectious Diseases Now","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idnow.2025.105126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105126"}}